Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Large-scale testing (Phase 3)UnknownNCT03601975What this trial is testingGemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 336
Early research (Phase 1)Study completedNCT00005647What this trial is testingSU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Case Comprehensive Cancer Center 12
Not applicableStudy completedNCT00851253What this trial is testingStereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Boston Medical Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06378177What this trial is testingLVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)Who this might be right forHead and Neck Squamous Cell Carcinoma Lyvgen Biopharma Holdings Limited 64
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT02143622What this trial is testingStudy of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma PatientsWho this might be right forHead and Neck Squamous Cell Carcinoma Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT00028496What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00060242What this trial is testingCombretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid CancerWho this might be right forHead and Neck Cancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305795What this trial is testingAn Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid TumorsWho this might be right forRecurrent Head and Neck Squamous Cell CarcinomaMetastatic Head-and-neck Squamous-cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more Rakuten Medical, Inc. 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206563What this trial is testingPenfluridol for Relapsed/Refractory Small Cell CancersWho this might be right forSmall Cell CarcinomaSmall Cell Carcinoma of LungSmall Cell Lung Cancer ( SCLC )+1 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33
Large-scale testing (Phase 3)Active Not RecruitingNCT06295731What this trial is testingINBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCCWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC) Inhibrx Biosciences, Inc 410
Not applicableUnknownNCT05821751What this trial is testingThe Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint InhibitorsWho this might be right forHead and Neck Squamous Cell Carcinoma Fondazione del Piemonte per l'Oncologia 40
Early research (Phase 1)Study completedNCT00002901What this trial is testingDocetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionWho this might be right forBreast CancerHead and Neck CancerLung Cancer+2 more City of Hope Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783581What this trial is testingProton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI TrialWho this might be right forLocally Advanced Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma Mayo Clinic 30
Early research (Phase 1)UnknownNCT04282070What this trial is testingSHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Jiangsu HengRui Medicine Co., Ltd. 91
Large-scale testing (Phase 3)Ended earlyNCT06790966What this trial is testingPhase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forRecurrent Head and Neck CancerMetastatic Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more PDS Biotechnology Corp. 12
Not applicableEnded earlyNCT05003856What this trial is testingRadiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid NoduleWho this might be right forBenign Thyroid Gland NeoplasmRecurrent Thyroid Gland CarcinomaThyroid Gland Follicular Tumor of Uncertain Malignant Potential+2 more M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)WithdrawnNCT06513884What this trial is testingHB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal CancerWho this might be right forOropharyngeal Squamous Cell Carcinoma Recurrent Hookipa Biotech GmbH